Edition:
United Kingdom

Cadila Healthcare Ltd (CADI.NS)

CADI.NS on National Stock Exchange of India

340.00INR
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
Rs340.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,467,594
52-wk High
Rs519.45
52-wk Low
Rs332.75

Latest Key Developments (Source: Significant Developments)

Cadila Healthcare Says Zydus Gets Final Nod From U.S. FDA For Nystatin Ointment And Omeprazole And Sodium Bicarbonate Capsules
Monday, 28 May 2018 

May 28 (Reuters) - Cadila Healthcare Ltd ::ZYDUS RECEIVES FINAL APPROVAL FROM USFDA FOR NYSTATIN OINTMENT USP AND OMEPRAZOLE AND SODIUM BICARBONATE CAPSULES.  Full Article

Cadila Healthcare Says Zydus Gets U.S. FDA Final Nod For Dutasteride, Tamsulosin Hydrochloride Capsules
Friday, 25 May 2018 

May 25 (Reuters) - Cadila Healthcare Ltd ::SAYS ZYDUS RECEIVES FINAL APPROVAL FROM USFDA FOR DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES.DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES WILL BE MANUFACTURED AT GROUP'S MANUFACTURING FACILITY AT MORAIYA.  Full Article

Cadila Healthcare Says Zydus Cadila Got USFDA Nod For Drug to Treat Parkinson's Symptoms
Thursday, 10 May 2018 

May 10 (Reuters) - Cadila Healthcare Ltd ::ZYDUS CADILA RECEIVES FINAL APPROVAL FROM USFDA FOR CARBIDOPA TABLETS.DRUG TO TREAT SYMPTOMS OF PARKINSON'S DISEASE; WILL BE MANUFACTURED AT FACILITY AT SEZ, AHMEDABAD.  Full Article

India's Cadila Healthcare Says No Observation Issued For Topical Unit
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Cadila Healthcare Ltd ::SAYS TOPICAL FACILITY SUCCESSFULLY COMPLETES USFDA INSPECTION.NO OBSERVATIONS WERE ISSUED.  Full Article

Cadila Healthcare's ‍Zydus Partners With Medicure To Launch Zypitamag In U.S.​
Thursday, 8 Mar 2018 

March 8 (Reuters) - Cadila Healthcare Ltd ::UNIT ‍ZYDUS PARTNERS WITH MEDICURE TO LAUNCH ITS NDA PRODUCT, ZYPITAMAG (PITAVASTATIN) IN U.S.​.  Full Article

Cadila Healthcare's ‍Zydus Gets Final Nod From U.S. FDA For Sedative Injection​
Wednesday, 28 Feb 2018 

Feb 28 (Reuters) - Cadila Healthcare Ltd ::UNIT ‍ZYDUS GETS FINAL NOD FROM U.S. FDA FOR DEXMEDETOMIDINE HYDROCHLORIDE INJECTION.INJECTION TO BE MANUFACTURED AT CO'S FORMULATIONS MANUFACTURING FACILITY AT MORAIYA, AHMEDABAD‍​​.  Full Article

Cadila Healthcare's Moraiya Facility Successfully Completes U.S. FDA Inspection
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Cadila Healthcare Ltd ::SAYS CO'S MORAIYA FACILITY SUCCESSFULLY COMPLETES U.S. FDA INSPECTION.SAYS NO OBSERVATION (483) IS ISSUED.  Full Article

India's Cadila Healthcare Dec Qtr Consol Profit Up About 68 Pct
Thursday, 8 Feb 2018 

Feb 8 (Reuters) - India's Cadila Healthcare Ltd ::DEC QUARTER CONSOL NET PROFIT 5.43 BILLION RUPEES VERSUS 3.24 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL NET PROFIT WAS 5.29 BILLION RUPEES.DEC QUARTER CONSOL SALES 31.92 BILLION RUPEES VERSUS 23.02 BILLION RUPEES LAST YEAR.  Full Article

Cadila Healthcare's Moraiya Manufacturing Facility Inspected By U.S. FDA
Wednesday, 7 Feb 2018 

Feb 7 (Reuters) - Cadila Healthcare Ltd ::SAYS MANUFACTURING FACILITY AT MORAIYA BEING INSPECTED BY U.S. FDA.  Full Article

Glenmark Pharmaceuticals Launches Biosimilar Of Adalimumab In India
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Glenmark Pharmaceuticals Ltd ::LAUNCHES BIOSIMILAR OF ADALIMUMAB IN INDIA.  Full Article